Apis -“We Care”

APIs -“We care”

ACTIVE PHARMACEUTICAL INGREDIENTS PORTFOLIO

API CAS THERAPEUTIC CATHEGORY

Abiraterone acetate 154229‐18‐2 Antiandrogen

Aprepitant 170729‐80‐3 Antiemetic

Atovaquone 95233‐18‐4 Antimalarial

Atracurium besylate 64228‐81‐5 NMBA

Atropine base 51‐55‐8 Anticholinergic

Atropine sulfate 55‐48‐1 Anticholinergic

Benazepril HCl 86541‐74‐4 ACE Inhibitor

Bortezomib 179324‐69‐7 Antineoplastic

Captopril 62571‐86‐2 ACE Inhibitor

Cisatracurium besilate 96946‐42‐8 NMBA

Decitabine 2353‐33‐5 Antineoplastic

Desloratadine 100643‐71‐8 Antihistaminic

Deutetrabenazine 1392826‐25‐3 VMAT2 inhibitor

Dolasetron mesylate 115956‐13‐3 Antiemetic

Enalapril maleate 76095‐16‐4 ACE inhibitor

Enalaprilat 76420‐72‐9 ACE inhibitor

Enzalutamide 915087‐33‐1 Antiandrogen

Everolimus 159351‐69‐6 Antineoplastic

Fexofenadine HCl 153439‐40‐8 Antihistaminic

Flupirtine maleate 75507‐68‐5 Analgesic

Fosaprepitant dimeglumine 265121‐04‐8 Antiemetic

Gefitinib 184475‐35‐2 Antineoplastic

Gemcitabine HCl 122111‐03‐9 Antineoplastic

Lisinopril 83915‐83‐7 ACE inhibitor

Samples for R&D use in the United States are available as permitted under 35 USC § 271 (e)(1). Product currently under patent protection could be available only for R&D purposes, if this is allowed by local laws. Products covered by valid patents in any country are not offered or supplied to these countries. However, the final responsibility lies exclusively on the buyer. V5.3 www.farmhispaniagroup.com

APIs -“We care”

API CAS THERAPEUTIC CATHEGORY

Loratadine 79794‐75‐5 Antihistaminic

Metformin HCl 1115‐70‐4 Type 2 diabetes

Methotrexate 59‐05‐2 Antineoplastic

Milrinone 78415‐72‐2 PDE3 inhibitor

Mivacurium chloride 106861‐44‐3 NMBA

Moexipril HCl 82586‐52‐5 ACE inhibitor

Palonosetron HCl 135729‐62‐3 Antiemetic

Pemetrexed disodium 150399‐23‐8 Antineoplastic

Perindopril arginine 612548‐45‐5 ACE inhibitor

Perindopril erbumine 107133‐36‐8 ACE inhibitor

Pirfenidone 154229‐18‐2 Antifibrotic

Quinapril HCl 82586‐55‐8 ACE inhibitor

Ramipril 87333‐19‐5 ACE inhibitor

Rocuronium bromide 119302‐91‐9 NMBA

Sirolimus 53123‐88‐9 Immunosuppressant

Solifenacin succinate 242478‐38‐2 Urinary Incontinence

Sugammadex sodium 343306‐79‐6 NMB Reversal

Tacrolimus 104987‐11‐3 Immunosuppressant

Tetrabenazine* 58‐46‐8 VMAT2 inhibitor

Tipiracil HCl 183204‐72‐0 Antimetabolite

Trandolapril 87679‐37‐6 ACE inhibitor

Trifluridine 70‐00‐8 Antiviral/Antineoplastic

Vecuronium HBr 50700‐72‐6 NMBA *Only for non‐US territories

Farmhispania Group also offers exclusive contract development under strict confidentiality